Patients/populationInterventionComparisonOutcomes
Inpatients receiving empiric treatment for neutropenic sepsisEarly dischargeContinued inpatient care until antibiotics discontinued for at least 24 hours
  • Overtreatment
  • Death/critical care
  • Quality of life
  • Re-admission rate
  • Adverse events (hospital acquired infection)

From: Subsequent Treatment: guideline chapter seven

Cover of Neutropenic Sepsis: Prevention and Management of Neutropenic Sepsis in Cancer Patients
Neutropenic Sepsis: Prevention and Management of Neutropenic Sepsis in Cancer Patients.
NICE Clinical Guidelines, No. 151.
National Collaborating Centre for Cancer (UK).
Copyright © National Collaborating Centre for Cancer, 2012.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.